Cosgrove Kelly P, Batis Jeffery, Bois Frederic, Maciejewski Paul K, Esterlis Irina, Kloczynski Tracy, Stiklus Stephanie, Krishnan-Sarin Suchitra, O'Malley Stephanie, Perry Edward, Tamagnan Gilles, Seibyl John P, Staley Julie K
Department of Psychiatry, Yale University School of Medicine, 950 Campbell Ave, Mail Code 116A6, West Haven, CT 06516, USA.
Arch Gen Psychiatry. 2009 Jun;66(6):666-76. doi: 10.1001/archgenpsychiatry.2009.41.
Available levels of nicotinic acetylcholine receptors containing the beta(2) subunit (beta(2)-nAChR) are higher in recently abstinent tobacco smokers compared with participants who never smoked. Variations in beta(2)-nAChR availability during the course of abstinence may be related to the urge to smoke, the extent of nicotine withdrawal, and successful abstinence.
To examine changes in beta(2)-nAChR availability during acute and prolonged abstinence from tobacco smoking and to determine how changes in beta(2)-nAChR availability were related to clinical features of tobacco smoking.
Tobacco smokers participated in up to 4 iodide 123-labeled 5-iodo-A-85380 ([(123)I]5-IA) single-photon emission computed tomography (SPECT) scans during abstinence at 1 day (n = 7) and 1 (n = 17), 2 (n = 7), 4 (n = 11), and 6 to 12 (n = 6) weeks. Age-matched nonsmokers participated in a single [(123)I]5-IA SPECT scan. All participants completed 1 magnetic resonance imaging study.
Academic imaging center.
Tobacco smokers (n = 19) and an age-matched nonsmoker comparison group (n = 20). Main Outcome Measure The [(123)I]5-IA SPECT images were converted to distribution volume and were analyzed using regions of interest.
Compared with nonsmokers, beta(2)-nAChR availability in the striatum, cortex, and cerebellum of smokers was not different at 1 day of abstinence, was significantly higher at 1 week of abstinence, and was not different at 4 or at 6 to 12 weeks of abstinence. In smokers, beta(2)-nAChR availability was significantly lower in the cortex and cerebellum at 6 to 12 weeks compared with 1 week of abstinence. In addition, cerebellar beta(2)*-nAChR availability at 4 weeks of abstinence was positively correlated with craving on the day of the SPECT scan.
These data suggest that higher beta(2)-nAChR availability persists up to 1 month of abstinence and normalizes to nonsmoker levels by 6 to 12 weeks of abstinence from tobacco smoking. These marked and persistent changes in beta(2)-nAChR availability may contribute to difficulties with tobacco cessation.
与从不吸烟的参与者相比,近期戒烟的吸烟者中含有β2亚基的烟碱型乙酰胆碱受体(β2 * -nAChR)的可用水平更高。戒烟过程中β2 * -nAChR可用性的变化可能与吸烟冲动、尼古丁戒断程度和成功戒烟有关。
研究急性和长期戒烟期间β2 * -nAChR可用性的变化,并确定β2 * -nAChR可用性的变化与吸烟临床特征的关系。
吸烟者在戒烟第1天(n = 7)、1周(n = 17)、2周(n = 7)、4周(n = 11)和6至12周(n = 6)期间参与了多达4次碘123标记的5-碘-A-85380([123I]5-IA)单光子发射计算机断层扫描(SPECT)扫描。年龄匹配的非吸烟者参与了一次[123I]5-IA SPECT扫描。所有参与者均完成了1次磁共振成像研究。
学术成像中心。
吸烟者(n = 19)和年龄匹配的非吸烟者对照组(n = 20)。主要观察指标 将[123I]5-IA SPECT图像转换为分布容积,并使用感兴趣区域进行分析。
与非吸烟者相比,吸烟者纹状体、皮质和小脑中β2 * -nAChR的可用性在戒烟第1天无差异,在戒烟1周时显著更高,在戒烟4周或6至12周时无差异。在吸烟者中,与戒烟1周相比,6至12周时皮质和小脑中β2 * -nAChR的可用性显著降低。此外,戒烟4周时小脑β2 * -nAChR的可用性与SPECT扫描当天的渴望呈正相关。
这些数据表明,较高的β2 * -nAChR可用性在戒烟长达1个月时持续存在,并在戒烟6至12周时恢复到非吸烟者水平。β2 * -nAChR可用性的这些显著且持续的变化可能导致戒烟困难。